北京時(shí)間3月28日至30日，由美國(guó)心臟病學(xué)會(huì)（ACC）舉辦的心血管領(lǐng)域盛會(huì)——ACC.26學(xué)術(shù)會(huì)議將在美國(guó)新奧爾良隆重舉行。在為期三天的學(xué)術(shù)盛宴中，來(lái)自中國(guó)各大頂尖醫(yī)院的專(zhuān)家學(xué)者將在冠狀動(dòng)脈疾病、結(jié)構(gòu)性心臟病、心力衰竭、心臟影像、心律失常及心血管預(yù)防等多個(gè)前沿領(lǐng)域分享超百項(xiàng)研究成果。這些報(bào)告不僅展現(xiàn)了我國(guó)心血管學(xué)界深厚的科研實(shí)力，更將為全球心血管疾病的診療提供寶貴的“中國(guó)經(jīng)驗(yàn)”與創(chuàng)新思路。截止官網(wǎng)2月2日日程更新，POCKETIN對(duì)此進(jìn)行了整理，讓我們拭目以待！如有遺漏或錯(cuò)誤，歡迎留言指正。

03月28日

1004. Basic and Translational Ischemic Heart Disease
北京時(shí)間：22:30
LEUKOCYTE CELL-DERIVED CHEMOTAXIN 2 AS A REGULATOR OF ENDOTHELIAL ANGIOGENESIS AND CARDIAC REMODELING AFTER MYOCARDIAL INFARCTION
白細(xì)胞源趨化素2作為心肌梗死后內(nèi)皮血管生成與心臟重構(gòu)的調(diào)節(jié)因子

鄒普 中南大學(xué)湘雅二醫(yī)院

CRISPR BASED RESTORATION OF MEX3A EXPRESSION RESCUES IMPAIRED AUTOPHAGY IN DIABETIC ATHEROSCLEROSIS MODELS
基于CRISPR技術(shù)恢復(fù)MEX3A表達(dá)可挽救糖尿病動(dòng)脈粥樣硬化模型中受損的自噬功能

許恒偉 陜西省人民醫(yī)院

NLRP3 INFLAMMASOME INHIBITION RESCUES DEFECTIVE MITOPHAGY AND STABILIZES DIABETIC ATHEROSCLEROTIC PLAQUES
抑制NLRP3炎癥小體可挽救缺陷線(xiàn)粒體自噬并穩(wěn)定糖尿病動(dòng)脈粥樣硬化斑塊

張勇 陜西省人民醫(yī)院

1005. Advances in Hypertension Management
北京時(shí)間：22:30
SUSTAINED REDUCTIONS IN ANGIOTENSINOGEN AND BLOOD PRESSURE WITH AN RNA INTERFERENCE THERAPEUTIC: INTERIM RESULTS FROM A FIRST-IN-HUMAN PHASE 1 STUDY OF GW906 IN CHINA
一種RNA干擾療法實(shí)現(xiàn)血管緊張素原與血壓的持續(xù)降低：GW906中國(guó)首次人體1期研究的中期結(jié)果

李海燕 北京大學(xué)第三醫(yī)院

1007. Advancing Valve Interventions: Integrating Emerging Evidence to Refine Clinical Decision Making
北京時(shí)間：22:30
COMPARATIVE OUTCOMES OF TRANSCATHETER AORTIC VALVE REPLACEMENT USING A DEDICATED DEVICE VERSUS SURGICAL REPLACEMENT IN PURE NATIVE AORTIC REGURGITATION: A PROPENSITY SCORE-MATCHED ANALYSIS
使用專(zhuān)用器械經(jīng)導(dǎo)管主動(dòng)脈瓣置換術(shù)與外科手術(shù)治療單純性主動(dòng)脈瓣反流的比較結(jié)局：傾向評(píng)分匹配分析

Yuqiang Wang 四川大學(xué)華西醫(yī)院

1304. Ischemic Heart Diseases 01
北京時(shí)間：22:30
TOTAL AND COMPOSITIONAL PLAQUE BURDEN ON CORONARY CTA INDEPENDENTLY PREDICT SHORT-TERM RISK OF ACUTE MYOCARDIAL INFARCTION
冠狀動(dòng)脈CTA總斑塊負(fù)荷與成分斑塊負(fù)荷獨(dú)立預(yù)測(cè)急性心肌梗死短期風(fēng)險(xiǎn)

Jingyao Yang 首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院

RELATIONSHIP BETWEEN CYCLIC GMP-AMP (CGAMP) AND SEVERE CORONARY STENOSIS: INSIGHT FROM MACHINE LEARNING AND SHAPLEY ADDITIVE EXPLANATIONS ANALYSIS
環(huán)狀GMP-AMP（cGAMP）與重度冠狀動(dòng)脈狹窄的關(guān)系：來(lái)自機(jī)器學(xué)習(xí)與Shapley加性解釋分析的見(jiàn)解

Quan Zhang 中南大學(xué)湘雅二醫(yī)院

CORONARY CT ANGIOGRAPHY-DERIVED PREDICTORS OF PROGRESSION FROM NONOBSTRUCTIVE LESIONS TO CULPRIT LESIONS IN ACUTE MYOCARDIAL INFARCTION
冠狀動(dòng)脈CT血管造影衍生的非阻塞性病變進(jìn)展為急性心肌梗死罪犯病變的預(yù)測(cè)因子

Jingyao Yang 首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院

1306. Multimodal Imaging 01
北京時(shí)間：22:30
A NOVEL CCTA-BASED VASCULAR RISK SCORING SYSTEM PREDICTS CARDIOVASCULAR EVENTS IN NON-OBSTRUCTIVE CORONARY ARTERY DISEASE: RESULTS FROM THE CHINA CT-FFR STUDY-2
一種新型基于冠狀動(dòng)脈CTA的血管風(fēng)險(xiǎn)評(píng)分系統(tǒng)預(yù)測(cè)非阻塞性冠狀動(dòng)脈疾病心血管事件：來(lái)自中國(guó)CT-FFR研究-2的結(jié)果

Haixin Liu 中國(guó)人民解放軍東部戰(zhàn)區(qū)總醫(yī)院

1309. Valvular Diseases 01
北京時(shí)間：22:30
SYSTEMIC INFLAMMATION MODERATE THE ASSOCIATION BETWEEN URINARY POLYCYCLIC AROMATIC HYDROCARBON METABOLITES AND HYPERTENSIVE ADULTS
全身性炎癥調(diào)節(jié)尿液中多環(huán)芳烴代謝物與高血壓成人之間的關(guān)聯(lián)

祝領(lǐng) 陜西省人民醫(yī)院

03月29日

1017. From Protocols to Partnerships: Operational Strategies Transforming Cardiovascular Care
北京時(shí)間：00:00
REAL-WORLD EFFECTIVENESS OF NURSE-LED ENHANCED RECOVERY PATHWAYS IN CARDIAC SURGERY: ASSOCIATIONS WITH FEWER COMPLICATIONS AND LOWER RESOURCE USE
護(hù)士主導(dǎo)的加速康復(fù)路徑在心臟外科中的真實(shí)世界效果：與更少并發(fā)癥和更低資源消耗相關(guān)

Jinyao Su 陜西省人民醫(yī)院

1019. Cellular Biology of Atherosclerotic Plaque
北京時(shí)間：00:00
MEX3A DEFICIENCY AMPLIFIES FERROPTOSIS AND ACCELERATES NECROTIC CORE EXPANSION IN DIABETIC ATHEROSCLEROSIS
MEX3A缺乏放大鐵死亡并加速糖尿病動(dòng)脈粥樣硬化中的壞死核心擴(kuò)展

劉仲偉 陜西省人民醫(yī)院

OXIDIZED LDL TRIGGERS PYROPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS AND SALIDROSIDE TREATMENT MITIGATES THIS PATHWAY TO IMPROVE PLAQUE STABILITY
氧化低密度脂蛋白觸發(fā)血管平滑肌細(xì)胞發(fā)生細(xì)胞焦亡，而紅景天苷治療可減輕該通路以改善斑塊穩(wěn)定性

許恒偉 陜西省人民醫(yī)院

1020. Aldosterone Synthase Inhibitors: What's New?
北京時(shí)間：00:00
VB19055: A NOVEL ALDOSTERONE SYNTHASE INHIBITOR WITH IMPROVED SELECTIVITY AND EFFICACY
VB19055：一種具有改進(jìn)的選擇性和效力的新型醛固酮合酶抑制劑

DOUGLAS FANG 浙江揚(yáng)厲醫(yī)藥科技有限公司

1021. A Jambalaya of Knowledge: Pulmonary Vascular Disease
北京時(shí)間：00:00
DECIPHERING THE COMMON MECHANISMS OF PULMONARY HYPERTENSION SUBTYPES USING MULTI-OMICS AND MACHINE LEARNING
利用多組學(xué)與機(jī)器學(xué)習(xí)解析肺動(dòng)脈高壓亞型的共同機(jī)制

郭媛 中南大學(xué)湘雅醫(yī)學(xué)院附屬株洲醫(yī)院

1030. ACC Complex Clinical Cases: Heart Failure and Cardiomyopathies (Session 2)
北京時(shí)間：00:00
FABRY CARDIOMYOPATHY PRESENTING AS HYPERTROPHIC PHENOTYPE WITH LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION: A CASE SERIES
表現(xiàn)為左室流出道梗阻肥厚表型的法布里心肌?。翰±盗?br/>

黃畢 重慶醫(yī)科大學(xué)附屬第一醫(yī)院

1325. Featured Fields 02
北京時(shí)間：00:00
THE ASSOCIATION BETWEEN BIOLOGICAL AGING AND CORONARY MICROVASCULAR DYSFUNCTION
生物衰老與冠狀動(dòng)脈微血管功能障礙的關(guān)聯(lián)

陸浩 復(fù)旦大學(xué)附屬中山醫(yī)院

1326. Cardiovascular Disease Prevention 02
北京時(shí)間：00:00
THE ARTIFICIAL SWEETENER SUCRALOSE MAY EXACERBATE ATHEROSCLEROSIS VIA ALTERATIONS IN GUT MICROBIOTA AND METABOLITE PROFILES
人工甜味劑三氯蔗糖可能通過(guò)改變腸道菌群和代謝物譜加劇動(dòng)脈粥樣硬化

Y. Feng 長(zhǎng)沙市

B LYMPHOCYTES CONTRIBUTE ANGIOTENSIN II INDUCED CARDIAC HYPERTROPHY
B淋巴細(xì)胞參與血管緊張素II誘導(dǎo)的心臟肥厚

伍航利 陜西省人民醫(yī)院

PK/PD CHARACTERISTICS OF BECONDOGREL IN HEALTHY SUBJECTS WITH DIFFERENT CYP2C19 METABOLIC GENOTYPES
BECONDOGREL在不同CYP2C19代謝基因型健康受試者中的藥代動(dòng)力學(xué)/藥效學(xué)特征

Ming Chen

1331. Cardiac Arrhythmias 02
北京時(shí)間：00:00
STEREOTACTIC BODY RADIOTHERAPY MODULATES ATRIAL ELECTROPHYSIOLOGY AND REDUCES ATRIAL FIBRILLATION SUSCEPTIBILITY: MECHANISTIC EVIDENCE FROM MURINE MODELS
立體定向體部放療調(diào)節(jié)心房電生理并降低心房顫動(dòng)易感性：來(lái)自小鼠模型的機(jī)制證據(jù)

Z. Jiang 北京

1332. Coronary, Peripheral and Structural Interventions 02
北京時(shí)間：00:00
ASSOCIATION BETWEEN NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL TO HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO (NHHR) AT ONE YEAR AFTER CORONARY ARTERY BYPASS GRAFTING AND LONG-TERM OUTCOMES IN PATIENTS WITH MULTIPLE VESSEL DISEASE: A RETROSPECTIVE COHORT STUDY
冠狀動(dòng)脈旁路移植術(shù)后1年非高密度脂蛋白膽固醇與高密度脂蛋白膽固醇比值（NHHR）與多支血管病變患者長(zhǎng)期結(jié)局的關(guān)聯(lián)：一項(xiàng)回顧性隊(duì)列研究

唐亮 中南大學(xué)湘雅二醫(yī)院

PROGNOSTIC VALUE OF THE ATHEROGENIC INDEX OF PLASMA IN PATIENTS WITH MULTIVESSEL CORONARY DISEASE UNDERGOING CABG: A RETROSPECTIVE COHORT STUDY
血漿致動(dòng)脈粥樣硬化指數(shù)對(duì)接受冠狀動(dòng)脈旁路移植術(shù)的多支冠狀動(dòng)脈疾病患者的預(yù)后價(jià)值：一項(xiàng)回顧性隊(duì)列研究

唐亮 中南大學(xué)湘雅二醫(yī)院

ADOPTION OF INTRAVASCULAR IMAGING-GUIDED PERCUTANEOUS CORONARY INTERVENTION IN THE UNITED STATES (2012-2022): TEMPORAL TRENDS, DISPARITIES, AND MORTALITY ASSOCIATION
美國(guó)血管內(nèi)成像引導(dǎo)的經(jīng)皮冠狀動(dòng)脈介入治療采用情況（2012-2022）：時(shí)間趨勢(shì)、差異與死亡率關(guān)聯(lián)

佟倩 吉林大學(xué)第一醫(yī)院

1347. Heart Failure and Cardiomyopathies 02
北京時(shí)間：00:00
NLRP3 INFLAMMASOME BLOCKADE IMPROVES VASCULAR-VENTRICULAR COUPLING AND DIASTOLIC FUNCTION AFTER TRANSVERSE AORTIC CONSTRICTION
阻斷NLRP3炎癥小體改善主動(dòng)脈弓縮窄術(shù)后血管-心室耦聯(lián)及舒張功能

潘碩 陜西省人民醫(yī)院

RESTORING THE ENDOTHELIAL GLYCOCALYX REVERSES NITRIC-OXIDE MECHANOTRANSDUCTION DEFECTS AND LIMITS PRESSURE-OVERLOAD REMODELING IN TAC
恢復(fù)內(nèi)皮糖萼可逆轉(zhuǎn)一氧化氮機(jī)械傳導(dǎo)缺陷并限制主動(dòng)脈弓縮窄模型中的壓力超負(fù)荷重構(gòu)

潘碩 陜西省人民醫(yī)院

DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR INTERMEDIATE- AND LONG-TERM SURVIVALIN PATIENTS WITH PERICARDITIS
心包炎患者中、長(zhǎng)期生存預(yù)測(cè)模型的建立與驗(yàn)證

lingyu Mi 中國(guó)醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院

C-REACTIVE PROTEIN TO ALBUMIN RATIO AND LONG-TERM MORTALITY IN PERICARDITIS
C反應(yīng)蛋白/白蛋白比值與心包炎患者的長(zhǎng)期死亡率

lingyu Mi 中國(guó)醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院

902. Highlighted Original Research: Valvular Diseases
北京時(shí)間：00:00
EARLY VERSUS CLASS I-TRIGGERED SURGERY IN SEVERE AORTIC REGURGITATION: IMPACT ON LONG-TERM SURVIVAL AND LEFT VENTRICULAR REMODELING
早期手術(shù)與I類(lèi)指征觸發(fā)手術(shù)在重度主動(dòng)脈反流中的比較：對(duì)長(zhǎng)期生存和左心室重構(gòu)的影響

Y. Wang 成都

1034. Cardiac Imaging Research: From Data to Decision
北京時(shí)間：01:30
AL18F-NOTA-PEG2-ECL1I: A NOVEL C-C CHEMOKINE RECEPTOR TYPE 2 RADIOTRACER FOR CARDIAC INFLAMMATION IMAGING
AL18F-NOTA-PEG2-ECL1I：一種用于心臟炎癥成像的新型CC趨化因子受體2放射性示蹤劑

Shuyang Song 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

1035. Innovation in Coronary Revascularization
北京時(shí)間：01:30
LONG-TERM PROGNOSTIC VALUE OF COMBINED IVUS AND ANGIOGRAPHY-DERIVED IMR ASSESSMENT IN INTERMEDIATE CORONARY STENOSIS: INSIGHTS FROM THE FLAVOUR STUDY
聯(lián)合血管內(nèi)超聲和血管造影衍生的微循環(huán)阻力指數(shù)評(píng)估對(duì)中度冠狀動(dòng)脈狹窄的長(zhǎng)期預(yù)后價(jià)值：來(lái)自FLAVOUR研究的見(jiàn)解

蔣峻 浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院

ENHANCED EXTERNAL COUNTERPULSATION IMPROVES CT-DERIVED FRACTIONAL FLOW RESERVE IN PATIENTS WITH INTERMEDIATE-RISK CHRONIC CORONARY SYNDROME: A PROSPECTIVE, MULTICENTER RANDOMIZED CONTROLLED TRIAL
增強(qiáng)型體外反搏改善中危慢性冠脈綜合征患者的CT衍生的血流儲(chǔ)備分?jǐn)?shù)：一項(xiàng)前瞻性多中心隨機(jī)對(duì)照試驗(yàn)

伍貴富 中山大學(xué)附屬第八醫(yī)院

1037. Evolving Tools For CVD Prediction
北京時(shí)間：01:30
COMPARATIVE PROGNOSTIC VALUE OF NINE CARDIORENAL BIOMARKERS FOR MORTALITY AMONG ADULTS WITH PREDIABETES AND DIABETES
九種心腎生物標(biāo)志物對(duì)糖尿病前期和糖尿病成人患者死亡率的比較預(yù)后價(jià)值

祝領(lǐng) 陜西省人民醫(yī)院

PROGNOSTIC VALUE OF FIBROSIS-4 INDEX FOR ALL-CAUSE AND CARDIAC MORTALITY IN PATIENTS WITH CORONARY HEART DISEASE COMBINED WITH DIABETES OR PREDIABETES:FINDINGS FROM TWO LARGE-SCALE PROSPECTIVE COHORT STUDIES
Fibrosis-4指數(shù)對(duì)合并糖尿病或糖尿病前期的冠心病患者全因及心臟性死亡率的預(yù)后價(jià)值：來(lái)自?xún)身?xiàng)大規(guī)模前瞻性隊(duì)列研究的發(fā)現(xiàn)

宋晨曦 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

1042. Unpacking HFpEF With Proteomics, Metabolism and Microvascular Mechanisms
北京時(shí)間：01:30
OXIDATIVELY DAMAGED MITOCHONDRIAL CARGO IN ADIPOCYTE EXTRACELLULAR VESICLES LINKS DIABETES TO HEART FAILURE WITH PRESERVED EJECTION FRACTION
脂肪細(xì)胞外泌體中的氧化損傷線(xiàn)粒體貨物將糖尿病與射血分?jǐn)?shù)保留的心力衰竭聯(lián)系起來(lái)

HAIBIN JI 南京醫(yī)科大學(xué)

TRANSCRIPTOME COMBINED WITH SINGLE-CELL ANALYSIS TO IDENTIFY GLUCOSE METABOLISM-RELATED KEY GENES IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION BY EMPAGLIFLOZIN
轉(zhuǎn)錄組結(jié)合單細(xì)胞分析鑒定恩格列凈治療射血分?jǐn)?shù)保留的心力衰竭中與葡萄糖代謝相關(guān)的關(guān)鍵基因

F. Wu 西安

1349. Featured Fields 03
北京時(shí)間：01:30
ASSOCIATION BETWEEN EARLY POSTOPERATIVE ADMINISTRATION OF PROTON PUMP INHIBITORS OR HISTAMINE 2 RECEPTOR ANTAGONIST AND POSTOPERATIVE DELIRIUM IN CARDIAC SURGERY PATIENTS
術(shù)后早期使用質(zhì)子泵抑制劑或組胺2受體拮抗劑與心臟手術(shù)患者術(shù)后譫妄的關(guān)聯(lián)

RAN AN 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

DEVELOPMENT AND VALIDATION OF AN INTERPRETABLE RISK PREDICTION MODEL FOR VA-ECMO-RELATED ACUTE KIDNEY INJURY IN CHILDREN: A MULTICENTER RETROSPECTIVE COHORT STUDY IN CHINA
兒童靜脈動(dòng)脈體外膜肺氧合相關(guān)急性腎損傷可解釋風(fēng)險(xiǎn)預(yù)測(cè)模型的開(kāi)發(fā)與驗(yàn)證：一項(xiàng)中國(guó)多中心回顧性隊(duì)列研究

R. Zhang 北京

PROGNOSTIC VALUE OF GLYCEMIC VARIABILITY FOR LONG-TERM MORTALITY IN CRITICALLY ILL PATIENTS WITH DIABETES AND CARDIOVASCULAR DISEASE
血糖變異性對(duì)合并心血管疾病的糖尿病危重癥患者長(zhǎng)期死亡率的預(yù)后價(jià)值

Yanfeng Yi 中南大學(xué)湘雅二醫(yī)院

1350. Cardiovascular Disease Prevention 03
北京時(shí)間：01:30
DEVELOPMENT OF AN ONLINE RISK CALCULATOR BASED ON THE REMNANT CHOLESTEROL INFLAMMATORY INDEX TO PREDICT MORTALITY IN U.S. ADULTS: A POPULATION-BASED STUDY
基于殘余膽固醇炎癥指數(shù)開(kāi)發(fā)在線(xiàn)風(fēng)險(xiǎn)計(jì)算器預(yù)測(cè)美國(guó)成人死亡率：一項(xiàng)基于人群的研究

陳艷 大連醫(yī)科大學(xué)附屬第二醫(yī)院

ASSOCIATION BETWEEN DIET PATTERNS AND PROGRESSION OF CORONARY ARTERY CALCIFICATION: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS
飲食模式與冠狀動(dòng)脈鈣化進(jìn)展的關(guān)聯(lián)：多民族動(dòng)脈粥樣硬化研究

M. Momin 北京

DISEASE BURDEN AND EPIDEMIOLOGY OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND SYSTEMIC INFLAMMATION IN EASTERN CHINA: A RETROSPECTIVE ELECTRONIC HEALTH RECORDS STUDY
中國(guó)東部地區(qū)動(dòng)脈粥樣硬化性心血管疾病、慢性腎臟病和系統(tǒng)性炎癥的疾病負(fù)擔(dān)與流行病學(xué)：一項(xiàng)回顧性電子健康記錄研究

馬根山 東南大學(xué)附屬中大醫(yī)院

ALCOHOL USE AT MID-LIFE AND ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY
中年期酒精使用與全因及特定原因死亡率

ziyue li 中南大學(xué)湘雅二醫(yī)院

1357. Valvular Diseases 03
北京時(shí)間：01:30
IMPACT OF THE WHOLE-LIFE CYCLE MANAGEMENT SYSTEM ON CLINICAL OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
全生命周期管理系統(tǒng)對(duì)經(jīng)導(dǎo)管主動(dòng)脈瓣置換術(shù)后臨床結(jié)局的影響

Z. Ran 成都

1358. Vascular Diseases 03
北京時(shí)間：01:30
ACUTE TYPE A AORTIC DISSECTION: DOES EXTENSIVE REPAIR OUTPERFORM PROXIMAL REPAIR?
急性A型主動(dòng)脈夾層：廣泛修復(fù)是否優(yōu)于近端修復(fù)？

Sichong Qian 首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院

1372. CV Team 04
北京時(shí)間：03:00
ELECTROCARDIOGRAPHIC AND RESPIRATORY MONITORING DURING SLEEP IN HYPERTENSIVE PATIENTS WITH PULMONARY HYPERTENSION
高血壓合并肺動(dòng)脈高壓患者睡眠期間心電圖與呼吸監(jiān)測(cè)研究

J. Liu 廣州

1373. Featured Fields 04
北京時(shí)間：03:00
IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDIAL FIBROSIS IS DRIVEN BY MACROPHAGE DERIVED EXOSOMES CARRYING PRO-FIBROTIC MICRORNAS
免疫檢查點(diǎn)抑制劑相關(guān)心肌纖維化由攜帶促纖維化微小RNA的巨噬細(xì)胞源性外泌體驅(qū)動(dòng)

張勇 陜西省人民醫(yī)院

1374. Cardiovascular Disease Prevention 04
北京時(shí)間：03:00
GUT MICROBIAL SIGNATURES OF HYPERTENSION ASSOCIATED WITH DIETARY AND SLEEP PHENOTYPES
與飲食和睡眠表型相關(guān)的高血壓腸道微生物特征

Xiaoyi Li 北京大學(xué)

SERUM URIC ACID, ARTERIAL STIFFNESS, AND MORTALITY: EVIDENCE FROM NHANES AND UK BIOBANK
血清尿酸、動(dòng)脈僵硬度與死亡率：來(lái)自NHANES與英國(guó)生物樣本庫(kù)的證據(jù)

J. Wen 佛山

MACROPHAGE TRPV6 DELETION ATTENUATES ATHEROSCLEROSIS BY INHIBITING FOAM CELL FORMATION
巨噬細(xì)胞TRPV6缺失通過(guò)抑制泡沫細(xì)胞形成減輕動(dòng)脈粥樣硬化

Feiyu Zhang 首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院

1379. Cardiac Arrhythmias 04
北京時(shí)間：03:00
ROLE OF DUAL THERAPIES WITH SACUBITRIL/VALSARTAN AND SGLT2 INHIBITORS IN REDUCED ARRHYTHMIC CLINICAL EVENTS AND HOSPITALISATIONS IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
沙庫(kù)巴曲/纈沙坦與SGLT2抑制劑雙重療法在減少植入式心律轉(zhuǎn)復(fù)除顫器患者心律失常臨床事件及住院率中的作用

Yap-Hang Chan 香港大學(xué)瑪麗醫(yī)院

1380. Coronary, Peripheral and Structural Interventions 04
北京時(shí)間：03:00
ANGIOGRAPHY-DERIVED FRACTIONAL FLOW RESERVE VERSUS INTRAVASCULAR ULTRASOUND TO GUIDE PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: A POST HOC ANALYSIS OF THE RANDOMIZED FLAVOUR II TRIAL
血管造影衍生血流儲(chǔ)備分?jǐn)?shù)與血管內(nèi)超聲指導(dǎo)伴或不伴慢性腎臟病患者經(jīng)皮冠狀動(dòng)脈介入治療的比較：隨機(jī)FLAVOUR II試驗(yàn)的事后分析

蔣峻 浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院

1381. Valvular Diseases 04
北京時(shí)間：03:00
ADIPOCYTE TRPM2 PROMOTES AORTIC DISSECTION BY ACCELERATING SMC PHENOTYPE SWITCHING
脂肪細(xì)胞TRPM2通過(guò)加速平滑肌細(xì)胞表型轉(zhuǎn)換促進(jìn)主動(dòng)脈夾層

王覓 中南大學(xué)湘雅二醫(yī)院

1382. Vascular Diseases 04
北京時(shí)間：03:00
SESTRIN2 ALLEVIATES HYPERTENSION BY INHIBITING FERROPTOSIS VIA THE AMPK/NRF2/GPX4 SIGNALING PATHWAY
Sestrin2通過(guò)AMPK/NRF2/GPX4信號(hào)通路抑制鐵死亡從而緩解高血壓

吳皓宇 陜西省人民醫(yī)院

GLP-1 RECEPTOR AGONISTS REPROGRAM VASCULAR SMOOTH MUSCLE CELL METABOLISM TO ATTENUATE EXTRACELLULAR MATRIX REMODELING UNDER HYPERGLYCEMIC STRESS
GLP-1受體激動(dòng)劑重編程血管平滑肌細(xì)胞代謝以減輕高糖應(yīng)激下的細(xì)胞外基質(zhì)重塑

劉仲偉 陜西省人民醫(yī)院

1392. Complex Clinical Cases: Cardiac Arrhythmias 04
北京時(shí)間：03:00
A RARE CASE OF ACQUIRED FREQUENT PVCS POST-HEART TRANSPLANT: TRANSMITTED FROM DONOR AND ELIMINATED BY ABLATION
一例罕見(jiàn)的心臟移植后獲得性頻發(fā)室性早搏：源自供體并通過(guò)消融術(shù)消除

Z. Jiang 北京

904. Highlighted Original Research: Vascular Diseases
北京時(shí)間：03:00
EMPAGLIFLOZIN AMELIORATES PATHOLOGICAL REMODELING IN THORACIC AORTIC ANEURYSM AND DISSECTION BY REDUCING THE UBIQUITINATION OF NLRP3 INFLAMMASOME
恩格列凈通過(guò)減少NLRP3炎癥小體的泛素化改善胸主動(dòng)脈瘤與夾層的病理性重構(gòu)

沈莉 中南大學(xué)湘雅二醫(yī)院

1071. Endovascular Intervention for Peripheral Arterial Disease
北京時(shí)間：04:30
MACHINE LEARNING FOR RISK STRATIFICATION AFTER ENDOVASCULAR REVASCULARIZATION IN PERIPHERAL ARTERY DISEASE
機(jī)器學(xué)習(xí)在外周動(dòng)脈疾病血管內(nèi)血運(yùn)重建術(shù)后風(fēng)險(xiǎn)分層中的應(yīng)用

Y. Zhang 香港

1398. Cardiovascular Disease Prevention 05
北京時(shí)間：04:30
PREDICTING CPAP-INDUCED BLOOD PRESSURE REDUCTION USING AMBULATORY BLOOD PRESSURE MONITORING IN OBSTRUCTIVE SLEEP APNEA
利用動(dòng)態(tài)血壓監(jiān)測(cè)預(yù)測(cè)阻塞性睡眠呼吸暫停患者持續(xù)氣道正壓通氣治療誘導(dǎo)的血壓下降

謝江 首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院

DOSE-RESPONSE ASSOCIATIONS OF CIRCULATING LEVELS OF VERY-LONG-CHAIN SATURATED FATTY ACIDS WITH ALL-CAUSE MORTALITY IN PATIENTS WITH CARDIOVASCULAR DISEASEDOSE-RESPONSE ASSOCIATIONS OF CIRCULATING LEVELS OF VERY-LONG-CHAIN SATURATED FATTY ACIDS WITH ALL-CAUSE MORTALITY IN PATIENTS WITH CARDIOVASCULAR DISEASE
循環(huán)極長(zhǎng)鏈飽和脂肪酸水平與心血管疾病患者全因死亡率的劑量反應(yīng)關(guān)系

Z. Chen 長(zhǎng)沙

1400. Ischemic Heart Diseases 05
北京時(shí)間：04:30
PROGNOSTIC IMPLICATIONS OF CORONARY MICROVASCULAR DYSFUNCTION IN ST-ELEVATION MYOCARDIAL INFARCTION BY OBESITY STATUS
基于肥胖狀態(tài)的冠狀動(dòng)脈微血管功能障礙對(duì)ST段抬高型心肌梗死患者的預(yù)后影響

Q. Guo 北京

THE BURDEN OF TRADITIONAL RISK FACTORS MODIFIES THE ASSOCIATION BETWEEN LIPOPROTEIN(A) AND 10-YEAR CORONARY HEART DISEASE EVENT RISK
傳統(tǒng)危險(xiǎn)因素負(fù)荷修飾脂蛋白(a)與10年冠心病事件風(fēng)險(xiǎn)之間的關(guān)聯(lián)

Fanyong Xu 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

1405. Valvular Diseases 05
北京時(shí)間：04:30
LONG-TERM OUTCOMES OF J-VALVE TRANSCATHETER AORTIC VALVE REPLACEMENT IN AORTIC STENOSIS OR AORTIC REGURGITATION: A LARGE-SCALE RETROSPECTIVE COHORT STUDY
J-Valve經(jīng)導(dǎo)管主動(dòng)脈瓣置換術(shù)治療主動(dòng)脈瓣狹窄或主動(dòng)脈瓣反流的長(zhǎng)期結(jié)果：一項(xiàng)大規(guī)?；仡櫺躁?duì)列研究

S. He 成都

1406. Vascular Diseases 05
北京時(shí)間：04:30
RESIDUAL CARDIOVASCULAR RISK ASSOCIATED WITH CUMULATIVE NON-HDL CHOLESTEROL EXPOSURE IN PATIENTS WITH PERIPHERAL ARTERY DISEASE
外周動(dòng)脈疾病患者累積非高密度脂蛋白膽固醇暴露相關(guān)的殘余心血管風(fēng)險(xiǎn)

Y. Zhang 香港

1418. Complex Clinical Cases: Heart Failure and Cardiomyopathies 05
北京時(shí)間：04:30
MAVACAMTEN SIGNIFICANTLY REDUCES MIDVENTRICULAR OBSTRUCTION IN TWO PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A CASE SERIES
Mavacamten顯著減輕兩例肥厚型心肌病患者的心室中部梗阻：病例系列報(bào)告

Y. Miao 上海

1419. Heart Failure and Cardiomyopathies 05
北京時(shí)間：04:30
INTEGRATIVE TRANSCRIPTOMIC AND SINGLE-CELL ANALYSIS REVEALS MITOCHONDRIAL-RELATED GENE BIOMARKERS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
整合轉(zhuǎn)錄組學(xué)與單細(xì)胞分析揭示射血分?jǐn)?shù)保留的心力衰竭中線(xiàn)粒體相關(guān)基因生物標(biāo)志物

F. Wu 西安

A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM STUDY OF TRANS-FEMORAL PERCUTANEOUS INTRAMYOCARDIAL SEPTAL RADIOFREQUENCY ABLATION (TF-PIMSRA) IN PATIENTS WITH DRUG-REFRACTORY SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: THE PRIMO STUDY
一項(xiàng)關(guān)于經(jīng)股動(dòng)脈穿刺心肌室間隔射頻消融術(shù)治療藥物難治性癥狀性梗阻性肥厚型心肌病的前瞻性、單中心、單臂研究：PRIMO研究

Y. Huang 長(zhǎng)沙

INTERMUSCULAR ADIPOSE TISSUE DENSITY AS A SEX-SPECIFIC NOVEL PROGNOSTIC MARKER IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A COMPREHENSIVE SINGLE-CENTER RETROSPECTIVE STUDY
肌間脂肪組織密度作為射血分?jǐn)?shù)保留的心力衰竭患者性別特異性新型預(yù)后標(biāo)志物：一項(xiàng)綜合單中心回顧性研究

史凱蕾 復(fù)旦大學(xué)附屬華東醫(yī)院

1084. Evolving Non-Statin Lipid Therapies
北京時(shí)間：22:30
EFFICACY AND SAFETY OF LERODALCIBEP IN CHINESE PATIENTS WITH HYPERCHOLESTEROLEMIA:A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL
Lerodalcibep在中國(guó)高膽固醇血癥患者中的療效與安全性：一項(xiàng)隨機(jī)、雙盲、安慰劑對(duì)照的3期試驗(yàn)

霍勇 北京大學(xué)第一醫(yī)院

LIPID-LOWERING EFFICACY AND SAFETY OF RECATICIMAB IN DYSLIPIDEMIA PATIENTS WITH OR WITHOUT TYPE 2 DIABETES MELLITUS: A POOLED PATIENT-LEVEL SUBGROUP ANALYSIS
瑞卡西單抗在伴或不伴2型糖尿病的血脂異?；颊咧械慕抵熜c安全性：一項(xiàng)患者水平匯總的亞組分析

孫燕依 上海交通大學(xué)醫(yī)學(xué)院附屬瑞金醫(yī)院

1421. Featured Fields 06
北京時(shí)間：22:30
AEROBIC EXERCISE ATTENUATES PRESSURE-OVERLOAD CARDIOMYOPATHY VIA MICROBIOTA-BILE ACID-DEPENDENT RECRUITMENT OF GUT RORγT? TREGS
有氧運(yùn)動(dòng)通過(guò)菌群-膽汁酸依賴(lài)性招募腸道RORγt Treg細(xì)胞減輕壓力超負(fù)荷性心肌病

Leiling Liu 中南大學(xué)湘雅二醫(yī)院

AEROBIC EXERCISE IMPROVES PRESSURE OVERLOAD -INDUCED CARDIAC HYPERTROPHY BY REGULATING THE METABOLISM OF TREG CELLS
有氧運(yùn)動(dòng)通過(guò)調(diào)節(jié)Treg細(xì)胞代謝改善壓力超負(fù)荷誘導(dǎo)的心臟肥厚

Xiao Li 中南大學(xué)湘雅二醫(yī)院

266. ANOCA, INOCA and MINOCA Boot Camp
北京時(shí)間：23:45
Case Presentation: ANOCA - One Patient’s Journey From Diagnosis to Treatment
病例匯報(bào)：ANOCA——一位患者從診斷到治療的歷程

Ming-Jui Hung 中國(guó)臺(tái)灣

03月30日

1096. Critical Care Cardiology and Schr?dinger’s Cat: Predicting Mortality in Shock
北京時(shí)間：00:00
PROGNOSTIC VALUE OF THE LACTATE-ALBUMIN RATIO FOR 28-DAY MORTALITY IN CARDIOGENIC SHOCK
乳酸/白蛋白比值對(duì)心源性休克28天死亡率的預(yù)后價(jià)值

M. Liu 北京

1099. Advances in Detection and Prognosis of IHD
北京時(shí)間：00:00
A MAGNETOCARDIOGRAPHY-DERIVED NOMOGRAM FOR PREDICTING CORONARY STENOSIS IN PATIENTS WITH NORMAL RESTING ECG
用于預(yù)測(cè)靜息心電圖正?；颊吖跔顒?dòng)脈狹窄的心磁圖列線(xiàn)圖

Y. Jiang 蘇州

1100. Deep-Learning Innovation for Prevention
北京時(shí)間：00:00
A MULTIDIMENSIONAL MACHINE LEARNING MODEL INTEGRATING PCAT RADIOMICS AND CLINICAL RISK FOR PREDICTING INCIDENT CORONARY PLAQUE FORMATION: A LARGE CHINESE, MULTICENTER, COHORT STUDY
整合心周脂肪組織影像組學(xué)與臨床風(fēng)險(xiǎn)以預(yù)測(cè)冠狀動(dòng)脈斑塊形成的多維機(jī)器學(xué)習(xí)模型：一項(xiàng)中國(guó)多中心大型隊(duì)列研究

Li Suyu 蘇州大學(xué)附屬第三醫(yī)院

1102. Diagnostic Testing and Frameworks for Valvular Heart Disease: Evaluating Approaches for Prognostic Assessment
北京時(shí)間：00:00
PROGNOSTIC VALUE OF EXTRA-AORTIC VALVE CARDIAC DAMAGE IN MODERATE VERSUS SEVERE AORTIC STENOSIS
中度與重度主動(dòng)脈瓣狹窄患者中主動(dòng)脈瓣外心臟損害的預(yù)后價(jià)值

jingjing HE 中山大學(xué)附屬第一醫(yī)院

1106. Integrating Genotype, Proteome and Phenotype Driving Cardiomyopathy
北京時(shí)間：00:00
HYPOXIA RESPONSE AND VASCULAR SMOOTH MUSCLE CELL ACTIVATION DRIVE MICROENVIRONMENTAL REMODELING IN HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM SINGLE-CELL SEQUENCING
缺氧反應(yīng)與血管平滑肌細(xì)胞激活驅(qū)動(dòng)肥厚型心肌病的微環(huán)境重塑：來(lái)自單細(xì)胞測(cè)序的見(jiàn)解

Fangyu Liu 復(fù)旦大學(xué)附屬中山醫(yī)院

1107. Molecular and Digital Biomarkers in Cardiovascular Disease and Heart Failure
北京時(shí)間：00:00
LOW-DOSE SEMAGLUTIDE AMELIORATES PRESSURE OVERLOAD-INDUCED HEART FAILURE BY SUPPRESSING THE NAT10-AC4C-TGF-β1 AXIS
低劑量司美格魯肽通過(guò)抑制NAT10-AC4C-TGF-β1軸改善壓力超負(fù)荷誘導(dǎo)的心力衰竭

Y. Hu 上海

INFERENCE OF SUB-CLINICAL LEFT VENTRICULAR GEOMETRIC REMODELING WITH DEEP LEARNING UNCOVERS INSIGHTS INTO METABOLIC CARDIOVASCULAR DISEASE
利用深度學(xué)習(xí)推斷亞臨床左心室?guī)缀沃貥?gòu)揭示對(duì)代謝性心血管疾病的見(jiàn)解

Y. Ma 西安

1108. ACC Complex Clinical Cases: Cardiac Arrhythmias (Session 4)
北京時(shí)間：00:00
DOUBLE-SNARE RETRIEVAL OF A DISLODGED ATRIAL LEADLESS PACEMAKER: A CASE REPORT
雙圈套器回收脫位的心房無(wú)導(dǎo)線(xiàn)起搏器：病例報(bào)告

Sue-Ping Chang 臺(tái)灣大學(xué)醫(yī)學(xué)院附設(shè)醫(yī)院

1445. Featured Fields 07
北京時(shí)間：00:00
NATIONAL TRENDS, PREDICTORS, AND CLINICAL OUTCOMES OF MECHANICAL CIRCULATORY SUPPORT IN CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION: A DECADE IN REVIEW (2012-2021)
急性心肌梗死并發(fā)心源性休克患者機(jī)械循環(huán)支持的國(guó)家趨勢(shì)、預(yù)測(cè)因子及臨床結(jié)局：十年回顧（2012-2021）

佟倩 吉林大學(xué)第一醫(yī)院

1446. Cardiovascular Disease Prevention 07
北京時(shí)間：00:00
FRAILTY, GENETIC RISK, AND INFLAMMATORY MEDIATION IN CORONARY ARTERY DISEASE: EVIDENCE FROM A LARGE POPULATION-BASED COHORT
冠狀動(dòng)脈疾病中的衰弱、遺傳風(fēng)險(xiǎn)與炎癥介導(dǎo)：來(lái)自大規(guī)模人群隊(duì)列的證據(jù)

Y. Fang 北京

1452. Coronary, Peripheral and Structural Interventions 07
北京時(shí)間：00:00
LESION LENGTH DEPENDENT EFFECTS OF QUANTITATIVE FLOW RATIO GUIDED PERCUTANEOUS CORONARY INTERVENTION
定量血流比引導(dǎo)的經(jīng)皮冠狀動(dòng)脈介入治療的病灶長(zhǎng)度依賴(lài)性效應(yīng)

X. Feng 首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院

1467. Heart Failure and Cardiomyopathies 07
北京時(shí)間：00:00
DEVELOPMENT AND VALIDATION OF AN INTERPRETABLE PREDICTION MODEL FOR SUCCESSFUL WEANING FROM VA-ECMO IN PEDIATRIC PATIENTS: A MULTICENTER RETROSPECTIVE COHORT STUDY IN CHINA
用于預(yù)測(cè)兒科患者成功脫離靜脈-動(dòng)脈體外膜肺氧合的可解釋預(yù)測(cè)模型的開(kāi)發(fā)與驗(yàn)證：一項(xiàng)中國(guó)多中心回顧性隊(duì)列研究

張然 中國(guó)人民解放軍總醫(yī)院第六醫(yī)學(xué)中心

276. Featured Clinical Research III
北京時(shí)間：01:15
Coronary CT Derived Fractional Flow Reserve-guided Management Of Patients With Stable CAD: 3-year Outcomes From A Multicentre, Pragmatic, Open-label, Randomised Controlled Trial In China
冠狀動(dòng)脈CT衍生的血流儲(chǔ)備分?jǐn)?shù)指導(dǎo)的穩(wěn)定型冠狀動(dòng)脈疾病患者管理：一項(xiàng)中國(guó)多中心、實(shí)用性、開(kāi)放標(biāo)簽、隨機(jī)對(duì)照試驗(yàn)的3年結(jié)果

唐春香 中國(guó)人民解放軍東部戰(zhàn)區(qū)總醫(yī)院

Role Of Screening With Coronary Computed Tomography Angiography In Lipid Management In An Asymptomatic Chinese Population: A Community-based, Parallel-group, Open-label, Randomized Clinical Trial (RESPECT2)
冠狀動(dòng)脈CT血管造影篩查在無(wú)癥狀中國(guó)人群血脂管理中的作用：一項(xiàng)基于社區(qū)的、平行組、開(kāi)放標(biāo)簽、隨機(jī)臨床試驗(yàn)（RESPECT2）

郭翔 中國(guó)人民解放軍東部戰(zhàn)區(qū)總醫(yī)院

1115. Novel Therapeutics in MI and ACS Management
北京時(shí)間：01:30
EARLY VERICIGUAT ADJUNCTIVE THERAPY IMPROVES LEFT VENTRICULAR REMODELING IN POST-AMI PATIENTS WITH REDUCED EJECTION FRACTION
早期維利西呱輔助治療改善射血分?jǐn)?shù)降低的急性心肌梗死后患者的左心室重構(gòu)

D. Si 長(zhǎng)春

1117. A Po' Boy and Hot Sauce: Pulmonary Hypertension and Heart Failure
北京時(shí)間：01:30
COMPREHENSIVE BIOINFORMATIC ANALYSIS IDENTIFIES M6A METHYLATION AS A KEY MEDIATOR LINKING IMMUNITY TO IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
綜合生物信息學(xué)分析識(shí)別M6A甲基化為連接免疫與特發(fā)性肺動(dòng)脈高壓的關(guān)鍵介質(zhì)

劉娜 中南大學(xué)湘雅二醫(yī)院

1468. Featured Fields 08
北京時(shí)間：01:30
ACCELEROMETER-MEASURED PHYSICAL ACTIVITY PATTERNS AND RISK OF MACE AND MORTALITY IN HYPERTENSIVE ADULTS
加速度計(jì)測(cè)量的體力活動(dòng)模式與高血壓成人心血管不良事件及死亡風(fēng)險(xiǎn)的關(guān)系

B. Hu 中山

1471. Ischemic Heart Diseases 08
北京時(shí)間：01:30
INHIBITION OF LACTATE DEHYDROGENASE A REDIRECTS GLUCOSE METABOLISM TO THE PENTOSE PHOSPHATE PATHWAY TO PROTECT CARDIOMYOCYTES IN MYOCARDIAL ISCHEMIA-REPERFUSION INJURY
抑制乳酸脫氫酶A可將葡萄糖代謝重定向至磷酸戊糖途徑，以保護(hù)心肌缺血-再灌注損傷中的心肌細(xì)胞

Ke Zhu 心血管疾病國(guó)家重點(diǎn)實(shí)驗(yàn)室

IMMUNE CHECKPOINT PD-1 SHAPES THE IMMUNE RESPONSE AND FUNCTIONAL RECOVERY AFTER MYOCARDIAL INFARCTION
免疫檢查點(diǎn)PD-1塑造心肌梗死后的免疫反應(yīng)和功能恢復(fù)

X. Wang 西安

MYOCARDIAL FUNCTION AMELIORATING AND UNDERLING MECHANISMS FOR SDF-1α LOADED JANUS CARDIAC PATCH IN RATS AFTER MYOCARDIAL INFARCTION
負(fù)載SDF-1α的Janus心臟貼片改善大鼠心肌梗死后心肌功能及其潛在機(jī)制

張靜 陜西省人民醫(yī)院

1490. Heart Failure and Cardiomyopathies 08
北京時(shí)間：01:30
SEX DIFFERENCES IN CLINICAL CHARACTERISTICS, GENETIC PROFILES AND OUTCOMES OF LEFT VENTRICULAR HYPERTRABECULATION
冠狀動(dòng)脈CT衍生的血流儲(chǔ)備分?jǐn)?shù)指導(dǎo)的穩(wěn)定性冠狀動(dòng)脈疾病患者管理：一項(xiàng)中國(guó)多中心、實(shí)效性、開(kāi)放標(biāo)簽、隨機(jī)對(duì)照試驗(yàn)的3年結(jié)果

K.-Q. Yang 北京

908. Highlighted Original Research: Ischemic Heart Disease
北京時(shí)間：01:30
PAD4-KNOCKDOWN M2-TYPE CAR-MS ENGULF NEUTROPHIL EXTRACELLULAR TRAPS AND ALLEVIATE POST-MYOCARDIAL INFARCTION FIBROSIS
PAD4敲低的M2型CAR-MS吞噬中性粒細(xì)胞胞外誘捕網(wǎng)并減輕心肌梗死后的纖維化

S. He 成都

294. Cardiovascular Risk Reimagined: The Future of Stratification in Cardiovascular Care
北京時(shí)間：02:45
Future-Proofing the Young: Personalized Prevention for Early Cardiovascular Risk
為年輕人做好未來(lái)準(zhǔn)備：針對(duì)早期心血管風(fēng)險(xiǎn)的個(gè)性化預(yù)防

Dong Zhao 北京

1129. Innovations and Challenges in CV Risk of Immunotherapy
北京時(shí)間：03:00
GUT MICROBIOTA-DERIVED TRIMETHYLAMINE N-OXIDE IS ESSENTIAL IN IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS AND MAY SERVE AS A POTENTIAL PHARMACOLOGICAL TARGET
腸道微生物群衍生的氧化三甲胺在免疫檢查點(diǎn)抑制劑相關(guān)性心肌炎中至關(guān)重要，并可能作為潛在的藥理學(xué)靶點(diǎn)

楊新宇 吉林大學(xué)第一醫(yī)院

1133. Social Factors Driving Cardiovascular Outcomes
北京時(shí)間：03:00
SHIFT WORK, SLEEP DURATION, AND MYOCARDIAL DYNAMICS: A CARDIAC MAGNETIC RESONANCE STUDY OF UK BIOBANK
輪班工作、睡眠時(shí)長(zhǎng)與心肌動(dòng)態(tài)：一項(xiàng)基于英國(guó)生物樣本庫(kù)的心臟磁共振研究

Z. Chang 北京

1135. Drug Coated Balloon Technologies
北京時(shí)間：03:00
ONE-YEAR REAL-WORLD OUTCOMES OF THE BIOFREEDOM POLYMER-FREE DRUG-COATED STENT SYSTEM IN CHINESE PATIENTS AT HIGH BLEEDING RISK: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY
BioFreedom聚合物無(wú)載體藥物洗脫支架系統(tǒng)在高出血風(fēng)險(xiǎn)中國(guó)患者中的一年期真實(shí)世界結(jié)果：一項(xiàng)前瞻性、多中心、觀察性研究

G. Ma 東南大學(xué)附屬中大醫(yī)院

1493. Cardiovascular Disease Prevention 09
北京時(shí)間：03:00
UNSUPERVISED IDENTIFICATION OF SLEEP CARDIOMETABOLIC SUBTYPES AND THEIR ASSOCIATION WITH LONG TERM CARDIOVASCULAR EVENTS IN A COMMUNITY BASED COHORT
社區(qū)隊(duì)列中睡眠心臟代謝亞型的無(wú)監(jiān)督識(shí)別及其與長(zhǎng)期心血管事件的關(guān)聯(lián)

Z. Huang 北京

INTEGRATING LIVER FIBROSIS INTO THE CKM SYNDROME: EVIDENCE FROM A LARGE-SCALE POPULATION COHORT
將肝纖維化整合入心血管-腎臟-代謝綜合征：來(lái)自大規(guī)模人群隊(duì)列的證據(jù)

Yanwen Fang, MD Yanwen Fang 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

1494. Pulmonary Vascular Disease 09
北京時(shí)間：03:00
CORRELATION BETWEEN INFLAMMATORY MARKERS AND PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE
炎癥標(biāo)志物與先天性心臟病相關(guān)性肺動(dòng)脈高壓之間的相關(guān)性

戴海龍 昆明市延安醫(yī)院

1497. Multimodal Imaging 09
北京時(shí)間：03:00
FOUR-DIMENSIONAL ECHOCARDIOGRAPHY REVEALS THE IMPACT OF ACE GENE POLYMORPHISM ON EARLY DIASTOLIC FUNCTION IN HYPERTENSION
四維超聲心動(dòng)圖揭示ACE基因多態(tài)性對(duì)高血壓早期舒張功能的影響 X. Cheng

X. Cheng 蘇州

1514. Heart Failure and Cardiomyopathies 09
北京時(shí)間：03:00
DIFFERENTIAL EXPRESSION PROFILING OF E3 UBIQUITIN LIGASE GENES IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION VIA RNA SEQUENCING AND E3ATLAS-BASED ANALYSIS
通過(guò)RNA測(cè)序和基于E3Atlas的分析，對(duì)射血分?jǐn)?shù)保留的心力衰竭患者外周血單個(gè)核細(xì)胞中E3泛素連接酶基因進(jìn)行差異表達(dá)譜分析

陽(yáng)輝 中南大學(xué)湘雅二醫(yī)院

IMMUNE CHECKPOINT PD-1 ATTENUATES HEART FAILURE BY RESTRAINING CROSSTALK BETWEEN CD8? T CELLS AND CCR2? MACROPHAGES
免疫檢查點(diǎn)PD-1通過(guò)抑制CD8? T細(xì)胞與CCR2?巨噬細(xì)胞之間的交互作用減輕心力衰竭

J. Liu 西安

TRAF2-DEPENDENT MITOPHAGY RESTORES MITOCHONDRIAL FUNCTION AND PREVENTS RECURRENCE IN HEART FAILURE WITH IMPROVED EJECTION FRACTION
TRAF2依賴(lài)性線(xiàn)粒體自噬恢復(fù)線(xiàn)粒體功能并預(yù)防射血分?jǐn)?shù)改善的心力衰竭復(fù)發(fā)

Y. Ma 西安

PIEZO1 BLOCKADE ATTENUATES PRESSURE-OVERLOAD CARDIAC REMODELING UNDER STANDARDIZED ANESTHESIA CONDITIONS
標(biāo)準(zhǔn)化麻醉?xiàng)l件下阻斷Piezo1可減輕壓力超負(fù)荷心臟重構(gòu)

張玉明 陜西省人民醫(yī)院

ANESTHESIA-DEPENDENT MECHANOTRANSDUCTION THROUGH YAP/TAZ SIGNALING DRIVES PRESSURE-OVERLOAD FIBROSIS
麻醉依賴(lài)性的YAP/TAZ信號(hào)機(jī)械轉(zhuǎn)導(dǎo)驅(qū)動(dòng)壓力超負(fù)荷纖維化

張玉明 陜西省人民醫(yī)院

1154. Silencers, Stabilizers and Therapeutic Progress in Transthyretin Amyloidosis
北京時(shí)間：04:30
RNA INTERFERENCE THERAPEUTICS REDUCE CARDIAC ARRHYTHMIAS AND ARRHYTHMIC HOSPITALISATIONS IN NON-TAFAMIDIS USERS WITH TRANSTHYRETIN AMYLOIDOSIS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
RNA干擾療法減少未使用他法米定的轉(zhuǎn)甲狀腺素蛋白淀粉樣變性患者的心律失常及心律失常相關(guān)住院：一項(xiàng)隨機(jī)對(duì)照試驗(yàn)的薈萃分析

Yap-Hang Chan 香港大學(xué)瑪麗醫(yī)院

1155. Beyond the Scar: Mechanisms, Modifiers and Markers of Myocardial Fibrosis
北京時(shí)間：04:30
ASSESSMENT OF MYOCARDIAL STRAIN FOR PREDICTING CARDIAC DYSFUNCTION AND MYOCARDIAL FIBROSIS IN DUCHENNE MUSCULAR DYSTROPHY
評(píng)估心肌應(yīng)變以預(yù)測(cè)杜氏肌營(yíng)養(yǎng)不良癥的心臟功能障礙和心肌纖維化

M. HU 成都

MULTI-OMIC INSIGHTS INTO THE ASSOCIATIONS BETWEEN MODIFIABLE FACTORS AND MYOCARDIAL FIBROSIS
可調(diào)控因素與心肌纖維化關(guān)聯(lián)的多組學(xué)見(jiàn)解

Teng Hu 四川大學(xué)華西醫(yī)院

1516. Featured Fields 10
北京時(shí)間：04:30
KNOWLEDGE, ATTITUDE, AND PRACTICE BEHAVIORAL REINFORCEMENT BY SMART GUIDANCE ENGINE FOR VENOUS THROMBOEMBOLISM: A RANDOMIZED CONTROLLED TRIAL
智能指導(dǎo)引擎強(qiáng)化靜脈血栓栓塞癥知識(shí)、態(tài)度與實(shí)踐行為的隨機(jī)對(duì)照試驗(yàn)

B. Liu 北京

1517. Cardiovascular Disease Prevention 10
北京時(shí)間：04:30
DIETARY INDEX FOR GUT MICROBIOTA, ENTEROLACTONE AND CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME: SHARED GLUCOSE PATHWAYS AND MULTI-TARGET MECHANISMS
腸道微生物群飲食指數(shù)、腸內(nèi)酯與心血管-腎臟-代謝綜合征：共享的葡萄糖通路與多靶點(diǎn)機(jī)制

W. Wen 南方醫(yī)科大學(xué)順德醫(yī)院

321. Featured Clinical Research V
北京時(shí)間：21:30
Efficacy And Safety Of BHB/HRS-1893 In Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From A 12-week Phase 2 Study
BHB/HRS-1893治療癥狀性梗阻性肥厚型心肌病的有效性與安全性：一項(xiàng)為期12周的2期研究結(jié)果

康連鳴 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

1540. Featured Fields 11
北京時(shí)間：22:30
PRE-EXISTING HEART FAILURE AND SEPSIS OUTCOMES: A MULTICENTER COMPETING-RISKS AND TIME-VARYING EFFECT ANALYSIS
既往心力衰竭與膿毒癥結(jié)局：一項(xiàng)多中心競(jìng)爭(zhēng)風(fēng)險(xiǎn)與時(shí)間效應(yīng)分析

J. Liu 西安

CARDIAC SUBSTRUCTURE DOSE PARAMETERS AS PREDICTORS OF CARDIAC EVENTS IN ESOPHAGEAL CANCER PATIENTS FOLLOWING DEFINITIVE CHEMORADIOTHERAPY
心臟亞結(jié)構(gòu)劑量參數(shù)作為食管癌根治性放化療后心臟事件的預(yù)測(cè)因子

Yue Huang 云陽(yáng)縣人民醫(yī)院

1541. Cardiovascular Disease Prevention 11
北京時(shí)間：22:30
TIMP1 AS A PROMISING PLASMA BIOMARKER AND THERAPEUTIC TARGET FOR IDENTIFYING AT-RISK SEVERE STEATOTIC LIVER DISEASE
TIMP1作為一種有前景的血漿生物標(biāo)志物和治療靶點(diǎn)用于識(shí)別高風(fēng)險(xiǎn)嚴(yán)重脂肪肝病

李子昂 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

1542. Pulmonary Vascular Disease 11
北京時(shí)間：22:30
PREDICTIVE VALUE OF MULTIPLE INFLAMMATORY BIOMARKERS FOR FUNCTIONAL LIMITATION AT 3 MONTHS POST-ACUTE PULMONARY EMBOLISM
多種炎癥生物標(biāo)志物對(duì)急性肺栓塞后3個(gè)月功能受限的預(yù)測(cè)價(jià)值

B. Yang 北京

1562. Heart Failure and Cardiomyopathies 11
北京時(shí)間：22:30
KALLISTATIN AMELIORATES DIABETIC CARDIOMYOPATHY BY REDUCING OXIDATIVE STRESS THROUGH THE MIR-34A-SIRT1-FOXO1 PATHWAY
激肽釋放酶結(jié)合蛋白通過(guò)miR-34a-SIRT1-FOXO1通路減輕氧化應(yīng)激從而改善糖尿病心肌病

J. Li 佛山

911. Highlighted Original Research: Cardiac Arrhythmias
北京時(shí)間：22:30
INCIDENCE AND PROGNOSIS OF HEART FAILURE IN LEFT BUNDLE BRANCH BLOCK
左束支傳導(dǎo)阻滯患者心力衰竭的發(fā)生率與預(yù)后

Sijing Cheng 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

03月31日

1179. Improved Detection of ACS and CAD: Tests & Biomarkers
北京時(shí)間：00:00
MACHINE LEARNING-BASED IN-HOSPITAL OUTCOME PREDICTING VARIABLES FOR ACUTE CORONARY SYNDROME: ANALYSIS FROM THE CCC-ACS PROJECT IN CHINA
基于機(jī)器學(xué)習(xí)的急性冠狀動(dòng)脈綜合征院內(nèi)結(jié)局預(yù)測(cè)變量：來(lái)自中國(guó)CCC-ACS項(xiàng)目的分析

J. Fan 南京

1180. Linking Lipid Metrics to CVD Risks
北京時(shí)間：00:00
THE MONOCYTE TO HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO IS ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY AMONG INDIVIDUALS WITH HYPERTENSION
單核細(xì)胞與高密度脂蛋白膽固醇比值與高血壓患者全因及心血管死亡率相關(guān)

Rongting Zhang 上海東方醫(yī)院

IMPACT OF LDL-C AND APOLIPOPROTEIN B LEVEL DISCORDANCE AND ASSOCIATED LIPOPROTEIN PARTICLE ALTERATIONS ON CARDIOVASCULAR OUTCOMES IN A LARGE PRIMARY PREVENTION POPULATION
低密度脂蛋白膽固醇與載脂蛋白B水平不一致及相關(guān)脂蛋白顆粒改變對(duì)大規(guī)模一級(jí)預(yù)防人群心血管結(jié)局的影響

Yuan Du 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

1572. Valvular Diseases 12
北京時(shí)間：00:00
REAL-WORLD EFFECTIVENESS AND SAFETY OF DIRECT ORAL ANTICOAGULANTS VERSUS WARFARIN IN ASIAN PATIENTS WITH ATRIAL FIBRILLATION AND MITRAL STENOSIS:A PREVALENT NEW‐USER DESIGN STUDY
直接口服抗凝藥對(duì)比華法林在亞洲房顫合并二尖瓣狹窄患者中的真實(shí)世界有效性與安全性：一項(xiàng)基于現(xiàn)患新用藥用戶(hù)設(shè)計(jì)的研究

Y. Yang 香港

1573. Vascular Diseases 12
北京時(shí)間：00:00
LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND RISK OF ABDOMINAL AORTIC ANEURYSM RUPTURE: INSIGHTS FROM A MULTICENTER CASE-CONTROL STUDY
低密度脂蛋白膽固醇水平與腹主動(dòng)脈瘤破裂風(fēng)險(xiǎn)：來(lái)自多中心病例對(duì)照研究的見(jiàn)解

楊靜博 天津醫(yī)科大學(xué)總醫(yī)院

1578. Complex Clinical Cases: Ischemic Heart Diseases 12
北京時(shí)間：00:00
UNRAVELLING HEPARIN-INDUCED THROMBOCYTOPENIA UNDER MECHANICAL CIRCULATORY SUPPORT IN ACUTE MYOCARDIAL INFARCTION AND ARRHYTHMIC STORM
急性心肌梗死與心律失常風(fēng)暴患者機(jī)械循環(huán)支持下肝素誘導(dǎo)的血小板減少癥的探究

Q. WANG 北京

1581. Complex Clinical Cases: Structural Interventions 12
北京時(shí)間：00:00
TIME IS A VALVE: A STUCK LEAFLET AFTER IMPLANTATION OF A TAURUSELITE VALVE WITH SPONTANEOUS RESOLUTION IN A PATIENT WITH SEVERE MIXED AORTIC VALVE DISEASE
時(shí)間即是瓣膜：一例重度混合性主動(dòng)脈瓣疾病患者植入TaurusElite瓣膜后瓣葉卡頓的自發(fā)性緩解

牛文豪 上海長(zhǎng)征醫(yī)院

1586. Heart Failure and Cardiomyopathies 12
北京時(shí)間：00:00
THE VALUE OF CARDIOPULMONARY EXERCISE TESTING IN EVALUATING SUBCLINICAL CARDIAC DYSFUNCTION IN UNEXPLAINED DYSPNEA OVERWEIGHT PATIENTS
心肺運(yùn)動(dòng)試驗(yàn)在評(píng)估不明原因呼吸困難超重患者亞臨床心功能不全中的價(jià)值

褚松筠 北京大學(xué)第一醫(yī)院

LEVERAGING THE PROGNOSTIC NUTRITIONAL INDEX AS A NOVEL TOOL FOR HEART FAILURE RISK STRATIFICATION IN HYPERTENSION
利用預(yù)后營(yíng)養(yǎng)指數(shù)作為高血壓患者心力衰竭風(fēng)險(xiǎn)分層的新工具

J. Zhong 佛山

1192. Impact of Digital Health and AI in Outpatient and Preventative Cardiology
北京時(shí)間：01:30
DETECTING VALVULAR HEART DISEASE ASSOCIATED MURMUR WITH SMARTPHONE MICROPHONE
利用智能手機(jī)麥克風(fēng)檢測(cè)瓣膜性心臟病相關(guān)雜音

C. Wong 香港

1194. Hearts on Fire: Insights from Advanced Imaging
北京時(shí)間：01:30
A PLATELET-BASED MITOCHONDRIAL DELIVERY SYSTEM ALLEVIATE MYOCARDIAL ISCHEMIA-REPERFUSION INJURY VIA TARGETING MACROPHAGES
一種基于血小板來(lái)源的線(xiàn)粒體遞送系統(tǒng)通過(guò)靶向巨噬細(xì)胞減輕心肌缺血-再灌注損傷

陳妍梅 南方醫(yī)科大學(xué)南方醫(yī)院

1196. Adiposity-Driven Cardiometabolic Risk
北京時(shí)間：01:30
PROGNOSTIC IMPLICATIONS OF OBSTRUCTIVE SLEEP APNEA IN ACUTE CORONARY SYNDROME BY RESIDUAL CHOLESTEROL INFLAMMATION INDEX
殘余膽固醇炎癥指數(shù)揭示的阻塞性睡眠呼吸暫停對(duì)急性冠狀動(dòng)脈綜合征的預(yù)后意義

M. Zhang 北京

1202. Bench to Bedside Innovations in Heart Failure Care
北京時(shí)間：01:30
ENGINEERED MESENCHYMAL STROMAL CELL-DERIVED EXOSOMES IMPROVE DUCHENNE MUSCULAR DYSTROPHY ASSOCIATED CARDIOMYOPATHY
工程化間充質(zhì)基質(zhì)細(xì)胞來(lái)源的外泌體改善杜氏肌營(yíng)養(yǎng)不良癥相關(guān)心肌病

Huayan Xu 出生缺陷與相關(guān)婦兒疾病教育部重點(diǎn)實(shí)驗(yàn)室

1588. Cardiovascular Disease Prevention 13
北京時(shí)間：01:30
FRAILTY TRAJECTORY PATTERNS AND RISK OF CARDIOVASCULAR DISEASE: EVIDENCE FROM TWO PROSPECTIVE COHORTS
衰弱軌跡模式與心血管疾病風(fēng)險(xiǎn)：來(lái)自?xún)身?xiàng)前瞻性隊(duì)列的證據(jù)

M. Liu 北京

FIBROSIS-4 INDEX-DEFINED ADVANCED LIVER FIBROSIS PREDICTS CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Fibrosis-4指數(shù)定義的晚期肝纖維化預(yù)測(cè)急性冠狀動(dòng)脈綜合征患者的心血管事件

x. Kong 北京

ENHANCING LONG-TERM CARDIOVASCULAR RISK STRATIFICATION: INTEGRATING BIOMARKERS INTO THE VERY HIGH-RISK ASCVD DEFINITION IN ASIAN PATIENTS
加強(qiáng)長(zhǎng)期心血管風(fēng)險(xiǎn)分層：將生物標(biāo)志物整合到亞洲患者極高危動(dòng)脈粥樣硬化性心血管疾病的定義中

王浩宇 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

HEART RATE VARIABILITY AND AUTOMATIC POSITIVE AIRWAY PRESSURE VENTILATION IN PATIENTS WITH CARDIOVASCULAR DISEASE AND SLEEP APNEA
心血管疾病合并睡眠呼吸暫?；颊叩男穆首儺愋耘c自動(dòng)持續(xù)氣道正壓通氣治療

L. Wang 廣州

1590. Ischemic Heart Diseases 13
北京時(shí)間：01:30
TEMPORAL SHIFTS IN ISCHEMIC AND BLEEDING RISK DOMINANCE:THE ARC-HBR TRADE-OFF MODEL
缺血與出血風(fēng)險(xiǎn)主導(dǎo)地位隨時(shí)間的變化：ARC-HBR權(quán)衡模型

王浩宇 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

EFFECT OF PROLONGED ANTICOAGULATION ON MYOCARDIAL INJURY AFTER PRIMARY PCI FOR STEMI: RIGHT CMR SUBSTUDY
延長(zhǎng)抗凝治療對(duì)ST段抬高型心肌梗死直接經(jīng)皮冠狀動(dòng)脈介入治療后心肌損傷的影響：心臟磁共振亞組研究

Y. Guo 首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院

ASSOCIATION BETWEEN METABOLIC SCORE FOR INSULIN RESISTANCE AND ADVERSE CARDIAC OUTCOMES IN ACUTE CORONARY SYNDROME PATIENTS WITHOUT STANDARD MODIFIABLE CARDIOVASCULAR RISK FACTORS
胰島素抵抗代謝評(píng)分與無(wú)標(biāo)準(zhǔn)可調(diào)控心血管危險(xiǎn)因素的急性冠狀動(dòng)脈綜合征患者不良心臟結(jié)局的關(guān)聯(lián)

X. Zhang 北京

1594. Coronary, Peripheral and Structural Interventions 13
北京時(shí)間：01:30
WHO BENEFITS FROM ANGIOGRAPHY-DERIVED FFR-GUIDED REVASCULARIZATION? DEFINING THE BENEFICIAL POPULATION AND ITS KEY FEATURES
誰(shuí)從血管造影衍生的血流儲(chǔ)備分?jǐn)?shù)指導(dǎo)的血運(yùn)重建中獲益？明確獲益人群及其關(guān)鍵特征

王浩宇 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

1606. Complex Clinical Cases: Cardiac Arrhythmias 13
北京時(shí)間：01:30
GLOBAL RESET AND RESYNCHRONIZE-COMBINED BACHMANN BUNDLE AND HIS BUNDLE PACING
全球復(fù)位與再同步——聯(lián)合Bachmann束與希氏束起搏

褚松筠 北京大學(xué)第一醫(yī)院

366. Investigative Horizons III
北京時(shí)間：02:45
Artificial Intelligence Model For Evaluating Surgical Techniques Of Cardiac Surgeons
用于評(píng)估心臟外科醫(yī)生手術(shù)技術(shù)的人工智能模型

袁昕 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

來(lái)源：ACC.26、心關(guān)注